Jun 22, 2021 9:46am EDT JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
Jun 15, 2021 10:15am EDT JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board
Jun 10, 2021 10:15am EDT JanOne Engages DC Consulting LLC for Government and Private Sector Initiatives
Jun 08, 2021 9:45am EDT JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101
Feb 25, 2021 9:29am EST JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million
Sep 24, 2020 10:45am EDT JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study
Sep 22, 2020 9:45am EDT JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery Disease
